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ABSTRACT
A condensation reaction of 2-amino-l,3,4-thiadiazole with 2-pyrrolecarboxaldehyde to form tridentate NNN
donor Schiff base has been performed. The prepared Schiff base was further used for the formation of metal
complexes having stoichi2ometry [M(L).]Xn, where M=Cu(II) or Zn(II), L=N-(2-pyrrolylmethylene)-2-amino
1,3,4-thiadiazole, X=SO4 ", NO3", C204 or CH3CO:z and n=l or 2. The new compounds described here have
been characterized by their physical, spectral and analytical data, and have been screened against several
bacterial strains such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. The
antibacterial potency of the Schiff base increased upon chelation/complexation, having the same metal ion
(cation) but different anions opening up a novel approach in finding new ways to fight against antibiotic
resistant strains.
INTRODUCTION
Thiadiazoles are largely used as antibacterialI, antifungal2, antitumor3’4, diuretic5’6, antiepileptic7, antiulcer
9 I0 and antileukemia’ agents. These compounds possess such interesting biological properties that may be
conferred to them by their strong aromatic ring system. As ligands, they also provide many potential
12 14 binding sites for complexation and have obtained a diversified biological activity by the result of such
chelation. It has been suggested
6 that the interaction of the metal ion with potentially biologically active
compounds lead to destroy or greatly help to diminish
7-19 the role of bacteria-/virus-/cancer-associated
organisms and therefore, represent a significant route for designing and establishing novel metal-based
antibacterial, antiviral and anticancer therapies2. In previous works we have explored the biological
properties of thiadiazole-derived compounds and the effect of chelation on their bactericidal properties2. In
order to evaluate the role of anions staying outside of the coordination sphere of the metal chelate, we report
here metal chelates of the already reported
21 Schiff base, obtained by the condensation of 2-amino-l,3,4-
thiadiazole with 2-pyrrolcarboxaldehyde to form tridentate donor ligand, i.e., N-(2-pyrrolylmethylene)-
2-amino-l,3,4-thiadiazole (L)’ having the same metal ion (cation) but different anions such as, sulfate, nitrate,
acetate and oalate of the type [M(L)2]Xn where M=Cu(II) or Zn(II), L N-(2-pyrrolylmethylene)-2-amino-
1,3,4-thiadiazole (Fig. I), X-SO42, NO3, C2042 or CI-13CO2 and n=l or 2. These compounds have been
characterized and screened for their antibacterial activity against pathogenic strains of Escherichia oli,
Staphylococcus aureus, and Pseudomonas aeruginosa.
Fig. 1" Structure ofthe Schiff base (L)
EXPERIMENTAL
Material and Methods
All chemicals and solvents used in syntheses were of Analar grade purity. IR spectra were recorded on a
Philips Analytical PU 9800 FTIR spectrophotometer as KBr discs. UV-Visible spectra were obtained in DMF
on a Hitachi U-2000 double-beam spectrophotometer. C, H and N analyses was carried out by Butterworth
Laboratories Ltd. Conductance of the metal complexes was determined in DMF on a Hitachi YSI-32 model
conductometer. Magnetic measurements were made on solid complexes using the Gouy method. Melting
points were recorded on a Gallenkamp apparatus and are uncorrected.
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Preparation of the Metai(ll) Complexes
A warm ethanol solution (20 mL) of the Schiff base (0.002 M) was added to a magnetically stirred solution of
the respective metal(lI) salt (0.001 M) in distilled water (25 mL). The mixture was refluxed for h and
cooled thereafter to room temperature. On cooling, a precipitate was formed which was filtered, washed with
ethanol, acetone and ether, and dried by suction. Crystallization from aqueous ethanol (70:30) gave the
desired metal complex. All other metal derivatives were obtained following the same method.
Antibacterial Studies
The synthesized metal complexes, as well as the uncomplexed Schiff base were screened for their
antibacterial activity against pathogenic bacterial strains of Escherichia coli, Staphylococcus aureus and
Pseudomonas aeruginosa. The compounds were tested at a concentration of 30 tag/0.01 mL in DMF solution
using the paper disc diffusion method as reported as earlier33"37. The diameter of the susceptibility zones was
measured in mm. The measured susceptibility zones were the clear zones around the discs killing the
bacteria.
Table 1. Physical and Analytical Data ofthe Metal(II) Chelates ared in this study.
No Metal chelate/ Yield M.p (C) B.M. Calc (Found)%
Mol. Formula (%)
[Cu(L)9]SO4 [515.5] 60
C,AH,CuNOAS
[C/a(L)]fNO3)2 [543.5]
C,H,CuN,,O,S
[(U(I,)2](C2-04) [507.5]
C,,HI:CuNOS
[Ch(L)]CH3CO [537.5]
CIsH18CuNsO4S:
[Zu(L)]SO4 [517.4]
CHIZnNsO4S
[Zn(L)]O3) [545.4]
C,H,ZnN,,O,So
[zn(L](C04 [09.4]
C,HIZnNsOS:
[Zh(L)OCH3CO [539.4]
CsHsZnNsO4S
(decomp) (lttCfr) C H N
218-220 1.7
62 211-213 1.6
61 209-211
63 215-217
62 205-207
62 214-216
60 212-214
61 216-218
1.5
1.5
Dia
Dia
Dia
Dia
32.6 2.3 21.7
(32.9) (2.1) (21.5)
30.9 .2.2 25.8
(31.2) (2.4) (25.7)
37.8 2.4 22.1
(37.5)(2.0)(22.6)
40.2 3.3 20.8
(40.6) (3.1) (20.5)
32.5 2.3 21.6
(32.2) (2.7)(21.3)
30.8 2.2 25.7
(30.5)(2.6)(25.4)
37.7 2.4 22.0
(38.1) (2.7) (21.8)
40.0 3.3 20.8
(40.3) (3.7) (20.5)
RESULTS AND DISCUSSION
Physical Properties
The Schiff base (Fig. 1) was prepared by refluxing an appropriate amount of 2-amino-l,3,4-thiadiazole with
2-pyrrolcarboxaldehyde in ethanol in a molar ratio. The structure of the Schiff base was established as
reported
21 earlier. All metal complexes (1-8) (Table 1) were air stable and prepared by the stoichiometric
reaction of the corresponding metal(II) salts with the Schiff base ligand, in a molar ratio M:L of 1:2. These
complexes are intensely colored and amorphous solids, which decompose without melting. They are
insoluble in common organic solvents such as ethanol, methanol, chloroform or acetone being only soluble in
DMSO and DMF. Molar conductance values of the soluble complexes in DMF show their values (132-147
ohm’lcm2mol"1) indicating
22 that they are all electrolytic in nature.
IR Spectra
IR spectra of the reported Schiff base showed the absence of bands at 1735 and 3420 cm
"1 due to carbonyl
v(C=O) an v(NH2) stretching vibrations (present in the starting materials). Instead a strong new band at
23 N1640 cm assigned as azomethine v(HC=N) vibration appeared indicating condensation of the two
moieties. The comparison of the infrared spectra of the Schiff base with their metal chelates indicated that the
Schiff base was basically coordinated to the metal ions tridentately. The band appearing at 1640 cm-
due to
24 the azomethine vibration is shifted to lower frequency by-15-20 cm
1 indicating the participation of the
azomethine nitrogen in complexation. The band at 1620 cm
"1 assigned to the thiadiazole ring v(C=N)
vibrations is also shifted to lower frequency by --15 cm which is indicative
24 of the involvement of the
thiadiazole ring nitrogen in chelation. Further evidence of the coordination of the Schiff base with the metal
ions was shown by the appearance of a weak low frequency new band at 525-530 cm (Table 2). This was, in
25 turn, assigned to v(M-N). This new band was observable only in the spectra of the metal complexes and not
in the spectra of the uncomplexed Schiff base and thus confirm the participation of the nitrogen heteroatom in
the coordination.
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Table 2. IR and UV-Visible Spectra Data ofthe Metal(II) Chelates.
No IR (cm") ,max (cm’)
1625 (HC=N), 1605 (C=N), 525 (M-N).
1620 (HC=N), 1605 (C=N), 525 (M-N).
1620 (HC=N), 1605 (C=N), 530 (M-N).
1625 (HC=N), 1610 (C=N), 530 (M-N).
1620 (HC=N), 1610 (C=N), 525 (M-N).
1620 (HC=N), 1605 (C=N), 530 (M-N).
1625 (HC=N), 1605 (C=N), 525 (M-N).
1625 (HC=N), 1610 (C=N), 530 (M-N).
22,155, 30,140
22,265, 30,265
22,275, 30,375
22,270, 30,250
28,665
28,745
28,850
28,785
NMR Spectra
The NMR spectral data of the Schiff base as well as some of its Zn(II) complexes as chloride taken in
DMSO-d6 is reported earlier2. The Schiff base exhibited signals due to all the expected protons in their
expected region and has been fully identified from the integration curves found to be equivalent to the total
number of protons deduced from the proposed structure. These were compared with the reported
26 signals of
known structurally related compounds and give further support for the composition of this new Schiff base as
well as its complexes suggested by the IR and elemental analyses data. Comparison of the chemical shifts of
the uncomplexed Schiff base with those of the corresponding zinc(II) complexes show that some of the
resonance are shifted upon complexation. In each case, the protons assigned due to the heteroaromatic (C-N)
ring and azomethine (HC=N) were found
2t at around 7.3-8.8 ppm in the spectra of the Schiff base. These
protons undergo downfield shift in the zinc complexes indicating participation of these groups in
coordination with the metal ions. The same shifts were observed in the 3C NMR spectral data of the Schiff
base versus their zinc complexes.
Magnetic Moment and Electronic Spectra
The room temperature magnetic moment of the solid copper(II) complexes having tetrahedral or octahedral
geometry normally exhibits magnetic moments in the range 1.6-1.8 B.M. The magnetic moment of the
27 28 present Cu(II) complexes (Table 1) was found to lie in the range of 1.5-1.7 B.M, indicative of one
unpaired electron per Cu(II) ion, consistent with its distorted octahedral geometry. The Zn(II) complexes
were all found diamagnetic. The electronic spectra of the Cu(II) chelates (Table 2) showed absorption bands
between 10 Dq for a distorted octahedral geometry (Fig 2) corresponding29’3 to the transitions 2Eg 2T2g.
The bands observed at 22155-22275 cm and 30,140-30,375 cm may be assigned
3 to intra-ligand charge
transfer transitions. The diamagnetic Zn(II) complexes did not show any d-d bands and their spectra are
dominated by charge transfer bands. The charge transfer band at 28665-28850 cm was assigned
32 to 2Eg
2T2g transitions possibly in an octahedral environment (Fig 2).
Table 3. Antibacterial Activity Data ofthe Schiffbase and its Metal(II) chelates 1-8.
Schiffbase/
Chelate
M c r o
+++
+++
++++
b ial S
++
++-q-+
+++
+++
++++
++++ +++
7 +++ ++++
8 +++ ++++
pecies
c
+
++
+++
++
+++
+++
a Escherichia coli, b Staphylococcus aureus, c Pseudomonas aeruginosa
Inhibition zone diametermm (% inhibition): +, 6-10 (27-45 %); ++, 10-14
(45-64 %); +++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values are
relative to inhibition zone (22 mm) ofthe most active compound with 100 % inhibition.
The Schiff base and its complexes individually exhibited varying degrees of inhibitory effects on the growth
of the tested bacterial species (Table 3). The antibacterial results evidently show that the activity of the Schiff
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base became more pronounced and significant when coordinated to these metal ions. It was observed that
when the same metal chelate having different anions was individually screened, the degree of bactericidal
activity also varied. For example, the Cu(II) complex having nitrate as anion was more bactericidal than the
Cu(II) complex with sulfate, oxalate or acetate anions. Similarly, the Cu(II) complex oxalate was more
antibacterial than the complex having acetate, chloride or sulfate. Similar results were found in the case of
Zn(II) complexes. It is observed that the order of potency, in comparison to the metal complexes having
chloride anions evaluated and reported
2 earlier, is
NO3" > C2042- > CH3CO2" > CI" > SO42"
X NOa" > C2042 > CH3CO2 > Cl > SO42, M Cu(II) or Zn(II), n or 2
Fig. 2: Proposed Structure ofthe Metal(II) Complexes 1-8.
On the basis of these observations, it is claimed that the process of chelation dominantly affects the biological
behavior of the compounds that are potent against some bacterial strains. From these studies, it is also
proposed that different anions do play a significant role in the biological behavior of the metal chelates. It is
suspected that factors such as solubility, different dipole moment and cell permeability mechanisms may be
influenced by the presence of the different anions which in turn, affect the overall mechanism of permeation
through the lipoid layer ofthe organisms thus killing them more effectively and efficiently.
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